Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia
Status:
Withdrawn
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to test the safety and efficacy of VS-4718 in two types of
leukemia patients and to find the right dose of VS-4718 for future clinical trials.
Other purposes of this study include:
- Testing for study drug VS-4718 levels in blood over time and what happens to the study
drug in patients.
- To find out if there are certain biomarkers in leukemia patients that predict if and how
4718 study drug may or may not work.